ChemioCare secures financing

ChemioCare Inc., a pharmaceutical company working on a proprietary transdermal delivery platform, has closed a private round of financing, raising $Research Note – Subscriber ONLY content: read our research and get insight on this and other deals. We offer monthly or yearly recurring or one-time trial subscriptions. Subscribe today and see what you have been missing!

ChemioCare’s Vision is to transform current treatment of chemotherapy-induced nausea and vomiting through patch technology.

New York City and Vancouver based based ChemioCare is a newly formed BC company.

photo credit: ChemioCare

Ted Liu

Ted Liu, M.Sc. (Mining, Queen's), MBA (Finance, Toronto), is the Editor of Private Capital Journal,,, and the former Editor of Canadian Private Equity. Ted has been passionately tracking Canadian private capital industry since 1992, having most recently served as Research Director for The Canadian Venture Capital and Private Equity Association (CVCA).

Ted is the architect of CVCA infobase, and is the architect of CPE Media's, Canada's most sophisticated and advanced all private capital and public market financing database.